Mohamad Makhzoumi has bought stock on 20 days since Jul 2018
10% owner at Korro Bio, Inc., and 11 other companies
SEC CIK 0001630226 · Filings on SEC.gov ↗
Mohamad Makhzoumi's record
3 months after each buy, from the first price a copier could get.
6 buys since 2018 with 3 months of prices.
Companies
- KRRO Korro Bio, Inc.10% owner
- SGP SpyGlass Pharma, Inc.10% owner
- MBX MBX Biosciences, Inc.10% owner
- SVRA Savara Inc.10% owner
- GNCA Genocea Biosciences, Inc.10% owner
- TRVI Trevi Therapeutics, Inc.10% owner
- HOOD Robinhood Markets, Inc.Director
- MTCR Metacrine, Inc.10% owner
- MRKR Marker Therapeutics, Inc.10% owner
- RGLS Regulus Therapeutics Inc.10% owner
- AKUS Akouos, Inc.10% owner
- AVEO Aveo Pharmaceuticals, Inc.10% owner
Every filing
23 filings since Jul 2018, newest first
Korro Bio, Inc.
10% owner
Spyglass Pharma, Inc.
10% owner
Mbx Biosciences, Inc.
10% owner
Korro Bio, Inc.
10% owner
Savara Inc
10% owner
Genocea Biosciences, Inc.
10% owner
Trevi Therapeutics, Inc.
10% owner
Robinhood Markets, Inc.
Director
Metacrine, Inc.
10% owner
Marker Therapeutics, Inc.
10% owner
Regulus Therapeutics Inc.
10% owner
Akouos, Inc.
10% owner
Trevi Therapeutics, Inc.
10% owner
Regulus Therapeutics Inc.
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
About Mohamad Makhzoumi
Mohamad Makhzoumi is a prominent venture capitalist and Co-CEO of New Enterprise Associates (NEA), a global venture capital firm focused on technology and healthcare investments.( He first joined NEA in 2000 (with some sources noting 2005 as an Associate), advancing through roles including Managing General Partner, Healthcare, where he led the firm's global healthcare investing practice across digital health and life sciences, and later Co-President before becoming Co-CEO.( Makhzoumi's investment focus spans healthcare services and technology from early venture to late-stage growth; he has co-founded and incubated companies such as Radiology Partners, Strive Health, and Curana Health, and serves on boards including Aetion, AllyAlign Health, Bright Health, and the Lucile Packard Foundation for Children’s Health at Stanford.(
As a corporate insider, Makhzoumi is listed as a 10% owner of SpyGlass Pharma, Inc. (SGP), having recently acquired preferred stock valued at $15 million, reflecting significant confidence in the company's future.( He is based in NEA’s Menlo Park office and continues to support entrepreneurs in building transformative healthcare companies.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.